BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9928290)

  • 1. Agonist and antagonist binding to rabbit cortical 5-HT2A receptors: opposite effects of magnesium.
    Aloyo VJ; Salt GL; Hoffman ME; Harvey JA
    Ann N Y Acad Sci; 1998 Dec; 861():280. PubMed ID: 9928290
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
    López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.
    Battaglia G; Shannon M; Titeler M
    J Neurochem; 1984 Nov; 43(5):1213-9. PubMed ID: 6491656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanine nucleotides modulate cortical S2 serotonin receptors.
    Titeler M; Battaglia G; Shannon M
    J Recept Res; 1984; 4(7):705-12. PubMed ID: 6527358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlation with the profile for the human receptors.
    Aloyo VJ; Harvey JA
    Eur J Pharmacol; 2000 Oct; 406(2):163-9. PubMed ID: 11020478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    Pinto W; Battaglia G
    Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors.
    Chaouloff F; Kulikov A; Mormède P
    Eur J Pharmacol; 1997 Sep; 334(1):25-9. PubMed ID: 9346323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand.
    Johnson MP; Siegel BW; Carr AA
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):205-9. PubMed ID: 8857599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A; Monferini E; Borsini F
    Pharmacol Res; 2001 Feb; 43(2):179-83. PubMed ID: 11243720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
    Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
    Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of [m-methoxy 3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.
    Jackson J; Paulose CS
    Mol Cell Biochem; 1999 Sep; 199(1-2):81-5. PubMed ID: 10544955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
    Glennon RA; Metwally K; Dukat M; Ismaiel AM; De los Angeles J; Herndon J; Teitler M; Khorana N
    Curr Top Med Chem; 2002 Jun; 2(6):539-58. PubMed ID: 12052193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
    López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
    J Comp Neurol; 2001 Jan; 429(4):571-89. PubMed ID: 11135236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
    J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter.
    Rioux A; Fabre V; Lesch KP; Moessner R; Murphy DL; Lanfumey L; Hamon M; Martres MP
    Neurosci Lett; 1999 Mar; 262(2):113-6. PubMed ID: 10203244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
    López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
    Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM; Janssen PF; Leysen JE
    Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal cocaine exposure potentiates 5-HT(2a) receptor function in male and female rat offspring.
    Battaglia G; Cabrera-Vera TM; Van De Kar LD
    Synapse; 2000 Mar; 35(3):163-72. PubMed ID: 10657023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.